Thursday, December 22, 2022
- HHS Proposes to Standardize Electronic Health Care Attachments Transactions and Electronic Signature Processes to Improve the Care Experience for Patients and Providers
- Long-Term Care Hospital Provider Preview Reports: Review by January 17
- Inpatient Rehabilitation Facility Provider Preview Reports: Review by January 17
- Hospital Ownership Data Release
- Clotting Factor: CY 2023 Furnishing Fee
- Medicare Diabetes Prevention Program: CY 2023 Payment Rates
- CMS Burden Reduction News & Insights
- Medicare Part B Drug Pricing Files & Revisions: January Update
- Integrated Outpatient Code Editor: Version 24.0
- DMEPOS: Revised 2023 Fee Schedule Public Use File
- National Correct Coding Initiative: Annual Policy Manual Update & Information on Other Payers
- Clinical Laboratory Fee Schedule: CY 2023 Annual Update
- Hospital Outpatient Prospective Payment System: January 2023 Update
- Laboratory Edit Software Changes: April 2023
- New Medicare Part B Immunosuppressant Drug Benefit
- Extension of Changes to the Low-Volume Hospital Payment Adjustment and the Medicare Dependent Hospital Program — Revised
- Medicare Part B Inflation Rebate Guidance: Use of the 340B Modifier
- Rural Emergency Hospitals
- Intravenous Immune Globulin Demonstration — Revised
- Medicare Preventive Services — Revised
- CDC Interim Guidance: Antiviral Treatment of Influenza
- Important Updates from the CDC on COVID-19 Therapeutics for Treatment & Prevention
HHS Proposes to Standardize Electronic Health Care Attachments Transactions and Electronic Signature Processes to Improve the Care Experience for Patients and Providers
CMS, on behalf of HHS, issued the proposed rule, Adoption of Standards for Health Care Attachments Transactions and Electronic Signatures, and Modification to Referral Certification and Authorization Transaction Standard (CMS-0053-P). If finalized, the proposed rule would adopt standards for “health care attachments” transactions, such as medical charts, x-rays, and provider notes that document physician referrals and office or telemedicine visits. The modifications to the adopted Health Insurance Portability and Accountability Act of 1996 (HIPAA) transactions would support both health care claims and prior authorization transactions, standards for electronic signatures to be used in conjunction with health care attachments transactions, and a modification to the standard for the referral certification and authorization transaction. The proposed rule estimates a savings of $454 million annually in administrative costs and is a part of HHS’ and CMS ongoing efforts to significantly reduce paperwork burdens and empower health care providers to focus on direct patient care and streamline the care experience for patients and providers.
Visit Public Reporting for more information.
Visit Public Reporting for more information.
CMS continues to improve data transparency by making Medicare-certified hospital ownership data publicly available starting December 20. For the first time, researchers, state licensing officials, state and federal law enforcement agencies, and the public can identify common owners across hospitals. They can link this information to other data sources to identify the performance of facilities under common ownership.
The 2023 blood clotting factor furnishing fee is $0.250 per unit.
Read about the latest burden reduction news and insights:
- Proposed rule to expand access to health information and improve the prior authorization process
- Proposed modifications to the National Council for Prescription Drug Programs retail pharmacy standards and new pharmacy subrogation standard
- Reminder: eliminating certificates of medical necessity and durable medical equipment information forms
Learn about quarterly updates to the following average sales price (ASP) and not otherwise classified (NOC) pricing files effective for dates of service:
- January 1–March 31, 2023: January 2023 ASP and ASP NOC
- October 1–December 31, 2022: October 2022 ASP and ASP NOC
- July 1–September 30, 2022: July 2022 ASP and ASP NOC
- April 1–June 30, 2022: April 2022 ASP and ASP NOC
Learn about claims processing changes effective January 1, 2023, for:
- Hospital outpatient departments
- Community mental health centers
- Non-outpatient prospective payment system (PPS) hospital providers
- Limited services when provided in a home health (HH) agency that isn’t paid under the HH PPS
- Hospice patients for non-terminal illness treatment
Get updates to the Medicare National Correct Coding Initiative (NCCI) Policy Manual effective January 1, 2023.
See Billing & Coding Advice FAQs to learn what to do about other commercial payers who deny payment citing NCCI edits.
Learn about changes effective January 1, 2023:
- Mapping new clinical laboratory test codes
- Updates for laboratory costs subject to the reasonable charge payment
Learn about payment system updates and new codes for:
- Drugs, biologicals, and radiopharmaceuticals
- Other items and services
Learn about the new benefit effective January 1, 2023:
- Extension of Medicare coverage for immunosuppressant drugs beyond 36 months for certain patients with kidney transplants
- Coverage of premiums and cost sharing for some of these patients
Extension of Changes to the Low-Volume Hospital Payment Adjustment and the Medicare Dependent Hospital Program — Revised
Medicare Administrative Contractors have 60 days to reprocess affected claims.
Learn about the requirement to include a modifier on claims for separately payable Part B drugs and biologicals acquired under the 340B Program.
Learn about this new Medicare Part A provider type:
- Becoming a provider
- Billing and payment
- Reporting quality data
Learn about the 2023 payment rate for Q2052.
Learn about updates to Medicare preventive services, including:
- Colorectal cancer screening:
- Reduced coinsurance starting January 1, 2023, when a screening colorectal cancer procedure becomes diagnostic or therapeutic
- Reduced age for colorectal cancer screening tests effective January 1, 2023
- Include a follow-on screening colonoscopy if a non-invasive stool-based test returns a positive result effective January 1, 2023
- Flu shot: removed CPT code 90685 effective August 1, 2022.
- Sexually transmitted infection (STI) screening & high intensity behavioral counseling to prevent STIs: added CPT code 0353U for chlamydia DNA test effective October 1, 2022.
Seasonal influenza activity is high across the U.S. The CDC has received numerous anecdotal reports of availability issues for generic oseltamivir in some locations. This may continue to occur in some communities as influenza activity continues.
This Health Alert Network Health Advisory provides clinicians and public health officials with guidance for prioritizing oseltamivir for treatment and information on other influenza antivirals that are recommended for treating influenza in areas where oseltamivir is temporarily unavailable.
This CDC Health Alert Network Health Update supplements Health Advisories issued on April 25 and May 24 to emphasize that the majority of Omicron sublineages circulating in the United States have reduced susceptibility to the monoclonal antibody, bebtelovimab and the monoclonal antibody combination, cilgavimab and tixagevimab (EvusheldTM).
Antiviral therapeutics for the treatment of COVID-19, ritonavir-boosted nirmatrelvir (Paxlovid™), remdesivir (Veklury®), and molnupiravir (Lagevrio™), retain activity against currently circulating Omicron sublineages. These medications can prevent severe disease, hospitalization, and death and are widely available but have been underused.
This Health Update provides health care professionals, public health officials, and the public with guidance on improving use of therapeutics for treatment of COVID-19 and strategies to prevent serious outcomes of COVID-19.
This newsletter is current as of the issue date. View the complete disclaimer.
The Medicare Learning Network®, MLN Connects®, and MLN Matters® are registered trademarks of the U.S. Department of Health and Human Services (HHS).